BETA Quarterly Results, Profit & Loss, Balance Sheet (BETA)

BETA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • BETA Financials
  • BETA Shareholding Pattern
  • BETA Earnings Documents
  • BETA Announcements
  • BETA Corporate Actions
  • BETA Bulk, Block & Insider Deals
  • BETA Delivery Data
  • BETA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Beta Drugs Ltd (BETA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Beta Drugs Ltd reported sales of ₹137 Cr, operating profit of ₹30 Cr (OPM 22%) and net profit of ₹19 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

BETA quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales88941001038794126137
Expenses70768182707698107
Operating Profit1817202117182730
OPM21%18%20%21%19%19%22%22%
Other Income-12332322
Interest23344432
Depreciation34444545
Profit before tax1212161610122226
Tax25%26%25%26%19%24%25%25%
Net Profit991212991619
EPS in Rs8.868.9511.5912.118.48.9314.2516.73
BETA profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales184227296362385444
Expenses141174236288309352
Operating Profit435360757692
OPM23%23%20%21%20%21%
Other Income1112119
Interest22371513
Depreciation71010131718
Profit before tax344149575470
Tax28%25%25%26%24%-
Net Profit253136424153
EPS in Rs24.5830.4236.0842.0240.9248.31
Dividend Payout0%0%0%0%0%-
BETA balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital1010101011
Reserves148187211235427
Borrowings1513814614849
Other Liabilities82101121103170
Total Liabilities254436488496656
Fixed Assets6589112125220
CWIP00009
Investments00000
Other Assets190347376371427
Total Assets254436488496656
BETA cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3023313637
Cash from Investing Activity-22-19-14-36-51
Cash from Financing Activity-1-2-7118-8
Net Cash Flow729118-22
Free Cash Flow10519-1-16
CFO/OP69%44%52%48%49%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit6944524849
BETA ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days9010198103113
Inventory Days87106122127159
Days Payable123139145152172
Cash Conversion Cycle53687579100
Working Capital Days6173808297
ROCE36%34%33%27%19%
  • BETA Shareholding Pattern
  • BETA Earnings Concalls
  • BETA Growth Catalysts
  • BETA Corporate Actions
  • BETA Announcements
  • BETA Results & Documents
  • BETA Bulk & Block Deals
  • BETA Delivery Data